Alligator Bioscience
0.24 SEK
+9.07 %
Less than 1K followers
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+9.07 %
+33.39 %
+17.37 %
-28.61 %
-39.67 %
-83.74 %
-98.35 %
-99.65 %
-99.95 %
Alligator Bioscience is a research-based biotechnology company. The company uses a patented technology to develop biological drug candidates in inflammation and cancer, and is active in the earlier part of the drug development chain. Alligator Bioscience has a global technology platform and is active in the protein pharmaceutical segment. The company was founded in 2001 and is headquartered in Lund.
Read moreMarket cap
151.06M SEK
Turnover
6.76M SEK
Revenue
510K
EBIT %
-20,750.2 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5.5
2026
Interim report Q1'26
6.5
2026
General meeting '26
27.8
2026
Interim report Q2'26
All
Webcasts
Press releases
ShowingAll content types
New data from investigator‑initiated study evaluating Alligator Bioscience’s mitazalimab to be presented at AACR Annual Meeting 2026
Alligator Bioscience provides an update on mitazalimab
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools